Masayuki Nigo

Masayuki Nigo

Auto-generated profile, based on publicly available information

Masayuki Nigo

Center for Infectious Diseases, Houston Methodist Research Institute , Houston, Texas

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
MNMasayuki Nigo
Masayuki Nigo
LRLaila Rasmy
Laila Rasmy
BMBingyu Mao
Bingyu Mao
BKBijun Sai Kannadath
Bijun Sai Kannadath
ZXZiqian Xie
Ziqian Xie
DZDegui Zhi
Degui Zhi
Methicillin-resistant Staphylococcus aureus (MRSA) poses significant morbidity and mortality in hospitals. Rapid, accurate risk stratification of MRSA is crucial for optimizing antibiotic therapy. Our study introduced a deep learning model, PyTorch_EHR, which leverages electronic health record (EHR) time-series data, including wide-variety patient specific data, to predict MRSA culture positivity within two weeks. 8,164 MRSA and 22,393 non-MRSA patient events from Memorial Hermann Hospital System, Houston, Texas are used for model development. PyTorch_EHR outperforms logistic regression (LR) and light gradient boost machine (LGBM) models in accuracy (AUROCPyTorch_EHR = 0.911, AUROCLR = 0.857, AUROCLGBM = 0.892). External validation with 393,713 patient events from the Medical Information Mart for Intensive Care (MIMIC)-IV dataset in Boston confirms its superior accuracy (AUROCPyTorch_EHR = 0.859, AUROCLR = 0.816, AUROCLGBM = 0.838). Our model effectively stratifies patients into high-, medium-, and low-risk categories, potentially optimizing antimicrobial therapy and reducing unnecessary MRSA-specific antimicrobials. This highlights the advantage of deep learning models in predicting MRSA positive cultures, surpassing traditional machine learning models and supporting clinicians’ judgments.

1 March 2019 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
CNCima Nowbakht
Cima Nowbakht
AEAngelina R Edwards
Angelina R Edwards
DRDavid F Rodriguez-Buritica
David F Rodriguez-Buritica
ALAndrea M Luce
Andrea M Luce
PDPratik B Doshi
Pratik B Doshi
MNMasayuki Nigo
Masayuki Nigo
Hyperammonemia syndrome (HS) in immunocompromised patients was originally described in 1985 [1]. The original cases were three patients with acute leukemia in the absence of underlying liver diseases.

15 November 2022 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
RDRebecca Drummond
Rebecca Drummond
JDJigar V. Desai
Jigar V. Desai
AHAmy P. Hsu
Amy P. Hsu
VOVasileios Oikonomou
Vasileios Oikonomou
Donald C. VinhDonald C. Vinh
Donald C. Vinh
Michail LionakisMichail Lionakis
Michail Lionakis
Subcutaneous phaeohyphomycosis typically affects immunocompetent individuals following traumatic inoculation. Severe or disseminated infection can occur in CARD9 deficiency or after transplantation, but the mechanisms protecting against phaeohyphomycosis remain unclear. We evaluated a patient with progressive, refractory Corynespora cassiicola phaeohyphomycosis and found that he carried biallelic deleterious mutations in CLEC7A encoding the CARD9-coupled, β-glucan–binding receptor, Dectin-1. The patient’s PBMCs failed to produce TNF-α and IL-1β in response to β-glucan and/or C. cassiicola. To confirm the cellular and molecular requirements for immunity against C. cassiicola, we developed a mouse model of this infection. Mouse macrophages required Dectin-1 and CARD9 for IL-1β and TNF-α production, which enhanced fungal killing in an interdependent manner. Deficiency of either Dectin-1 or CARD9 was associated with more severe fungal disease, recapitulating the human observation. Because these data implicated impaired Dectin-1 responses in susceptibility to phaeohyphomycosis, we evaluated 17 additional unrelated patients with severe forms of the infection. We found that 12 out of 17 carried deleterious CLEC7A mutations associated with an altered Dectin-1 extracellular C-terminal domain and impaired Dectin-1–dependent cytokine production. Thus, we show that Dectin-1 and CARD9 promote protective TNF-α– and IL-1β–mediated macrophage defense against C. cassiicola. More broadly, we demonstrate that human Dectin-1 deficiency may contribute to susceptibility to severe phaeohyphomycosis by certain dematiaceous fungi.

17 August 2022 in Journal of Biomedical Informatics
Verified
Journal Article
Closed access
MNMasayuki Nigo
Masayuki Nigo
HTHong Thoai Nga Tran
Hong Thoai Nga Tran
ZXZiqian Xie
Ziqian Xie
HFHan Feng
Han Feng
BMBingyu Mao
Bingyu Mao
DZDegui Zhi
Degui Zhi

1 September 2021 in Journal of Clinical Virology
Verified
Journal Article
Closed access
GHGuy Handley
Guy Handley
SPStephanie Pankow
Stephanie Pankow
JBJennifer Dien Bard
Jennifer Dien Bard
RYRebecca Yee
Rebecca Yee
MNMasayuki Nigo
Masayuki Nigo
RHRodrigo Hasbun
Rodrigo Hasbun

13 April 2019 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
MAMohanad Al-Obaidi
Mohanad Al-Obaidi
RHRodrigo Hasbun
Rodrigo Hasbun
KVKaren J Vigil
Karen J Vigil
AEAngelina R Edwards
Angelina R Edwards
VCVioleta Chavez
Violeta Chavez
MNMasayuki Nigo
Masayuki Nigo
Disseminated strongyloidiasis in solid organ transplant recipients is a rare but devastating infection. In our center, we implemented a universal screening of all candidates for kidney transplantation. We assessed the seroprevalence and utility of universal screening for strongyloidiasis in our center. Patients were identified from our transplant referral list (from July 2012 to June 2017). Demographics, pretransplant laboratory, and serological screenings were retrospectively collected. For Strongyloides-seropositive (SSp) patients, data on travel history, symptoms, treatment, and stool ova and parasite examinations were extracted. Logistic regression and multiple imputation for missing data were performed. A total of 1689 patients underwent serological screening, of whom 168 (9.9%) were SSp. Univariate analysis revealed that SSp patients had higher rates of eosinophilia, diabetes mellitus, latent tuberculosis and were likely to be either Hispanic or Asian (P < .05). In multivariate analysis, eosinophilia (P = .01), diabetes mellitus (P = .02), and Asian race (P = .03) were associated with being SSp, but 45 (27%) of the SSp patients did not have any of these 3 factors, and 18 SSp patients (11%) had no epidemiological risk factors. All patients received ivermectin, and none developed disseminated strongyloidiasis. Of patients who underwent serological screening on multiple occasions, 6.8% seroconverted while waiting for kidney transplantation. We found a high rate of Strongyloides seropositivity among our kidney transplantation candidates. No epidemiological risk factors effectively predicted SSp status in our population, and universal screening identified a large number of patients without such factors. Serial screening should be considered when a long wait time is expected before transplantation.